Literature DB >> 14700177

Physiologic effects of CPAP: application and monitoring.

Tami Irwin Sherman1, Thomas Blackson, Suzanne M Touch, Jay S Greenspan, Thomas H Shaffer.   

Abstract

Although a wide array of respiratory care modalities has been employed to manage neonatal respiratory distress syndrome (RDS), the recent focus has emphasized strategies that correct lung pathophysiology while protecting the lung from further insult. Continuous positive airway pressure (CPAP) has remained a viable option for NICU infants since its introduction in 1971. Current methods of monitoring allow clinicians to troubleshoot and better understand the physiologic and clinical impact of administering CPAP to neonates with RDS. This article highlights the renewed interest in CPAP therapy and current methods of monitoring.

Entities:  

Mesh:

Year:  2003        PMID: 14700177     DOI: 10.1891/0730-0832.22.6.7

Source DB:  PubMed          Journal:  Neonatal Netw        ISSN: 0730-0832


  4 in total

1.  Is volume and leak monitoring feasible during nasopharyngeal continuous positive airway pressure in neonates?

Authors:  Hendrik S Fischer; Charles C Roehr; Hans Proquitté; Hannes Hammer; Roland R Wauer; Gerd Schmalisch
Journal:  Intensive Care Med       Date:  2009-11       Impact factor: 17.440

2.  Influence of nose and mouth leaks on peripheral oxygen saturation during continuous positive airway pressure in neonates.

Authors:  Hendrik Stefan Fischer; Charles Christoph Roehr; Hans Proquitté; Gerd Schmalisch
Journal:  World J Pediatr       Date:  2013-10-21       Impact factor: 2.764

3.  Continuous positive airway pressure in children with severe pneumonia and hypoxaemia in Papua New Guinea: an evaluation of implementation.

Authors:  Francis Pulsan; Kone Sobi; Trevor Duke
Journal:  Acta Paediatr       Date:  2019-04-11       Impact factor: 2.299

4.  CeasIng Cpap At standarD criteriA (CICADA): predicting a successful outcome.

Authors:  Yue Yin; Margaret Broom; Audrey Wright; Donna Hovey; Mohamed E Abdel-Latif; Bruce Shadbolt; David A Todd
Journal:  Eur J Pediatr       Date:  2015-08-01       Impact factor: 3.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.